Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.85
-0.39 (-2.74%)
Aug 19, 2026, 2:14 PM EDT - Market open
Surgery Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,366 | 3,309 | 3,114 | 2,743 | 2,539 | 2,225 | |
Revenue Growth | 3.99% | 6.24% | 13.52% | 8.03% | 14.12% | 19.62% |
Cost of Revenue | 2,608 | 2,544 | 2,369 | 2,096 | 1,964 | 1,734 |
Gross Profit | 757.9 | 765 | 745.6 | 647.5 | 574.9 | 491.4 |
Selling, General & Admin | 121.7 | 118.2 | 138.7 | 120.9 | 102.2 | 104 |
Other Operating Expenses | -10.2 | -8.7 | -20 | -7.5 | -19 | -15.5 |
Operating Expenses | 288.7 | 285.5 | 271.3 | 231.5 | 198 | 187.3 |
Operating Income | 469.2 | 479.5 | 474.3 | 416 | 376.9 | 304.1 |
Interest Expense | -293.9 | -272.6 | -201.7 | -193 | -234.9 | -221 |
Earnings From Equity Investments | 22.3 | 22.9 | 19.5 | 14.2 | 12.5 | 11.3 |
Other Non Operating Income (Expenses) | 12.5 | - | - | - | - | - |
EBT Excluding Unusual Items | 210.1 | 229.8 | 292.1 | 237.2 | 154.5 | 94.4 |
Merger & Restructuring Charges | -65.1 | -73.9 | -100.1 | -61.7 | -47.5 | -39.8 |
Gain (Loss) on Sale of Assets | -33.7 | -30.4 | -40.6 | -14.4 | -11.1 | -2.2 |
Legal Settlements | -7.6 | -7.3 | 0.8 | -10.6 | 29.3 | - |
Other Unusual Items | -1.3 | -1.3 | -5.1 | -15.5 | -14.9 | 28.8 |
Pretax Income | 102.4 | 116.9 | 147.1 | 135 | 110.3 | 81.2 |
Income Tax Expense | 20.5 | 18 | 134.6 | -0.3 | 23.3 | 10.5 |
Earnings From Continuing Operations | 81.9 | 98.9 | 12.5 | 135.3 | 87 | 70.7 |
Minority Interest in Earnings | -170.5 | -176.8 | -180.6 | -147.2 | -141.6 | -141.6 |
Net Income | -88.6 | -77.9 | -168.1 | -11.9 | -54.6 | -70.9 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 10.3 |
Net Income to Common | -88.6 | -77.9 | -168.1 | -11.9 | -54.6 | -81.2 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 128 | 127 | 126 | 126 | 92 | 72 |
Shares Outstanding (Diluted) | 128 | 127 | 126 | 126 | 92 | 72 |
Shares Change | 1.28% | 0.86% | 0.40% | 36.61% | 26.96% | 48.49% |
EPS (Basic) | -0.69 | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
EPS (Diluted) | -0.69 | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 187.6 | 195.6 | 209.7 | 205 | 78.2 | 29.5 |
Free Cash Flow Per Share | 1.46 | 1.54 | 1.66 | 1.63 | 0.85 | 0.41 |
Gross Margin | 22.51% | 23.12% | 23.94% | 23.60% | 22.64% | 22.08% |
Operating Margin | 13.94% | 14.49% | 15.23% | 15.16% | 14.84% | 13.67% |
Profit Margin | -2.63% | -2.35% | -5.40% | -0.43% | -2.15% | -3.65% |
Free Cash Flow Margin | 5.57% | 5.91% | 6.73% | 7.47% | 3.08% | 1.33% |
EBITDA | 646.4 | 655.5 | 626.9 | 534.1 | 491.7 | 402.9 |
EBITDA Margin | 19.20% | 19.81% | 20.13% | 19.47% | 19.36% | 18.11% |
D&A For EBITDA | 177.2 | 176 | 152.6 | 118.1 | 114.8 | 98.8 |
EBIT | 469.2 | 479.5 | 474.3 | 416 | 376.9 | 304.1 |
EBIT Margin | 13.94% | 14.49% | 15.23% | 15.16% | 14.84% | 13.67% |
Effective Tax Rate | 20.02% | 15.40% | 91.50% | - | 21.12% | 12.93% |